Oxidoreductase, NLI-interacting factor
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 19 |
NetGPI | no | yes: 0, no: 19 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0005829 | cytosol | 2 | 1 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pescher et al. (upgregulation) | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: A4I9T8
Term | Name | Level | Count |
---|---|---|---|
GO:0006470 | protein dephosphorylation | 5 | 1 |
GO:0006793 | phosphorus metabolic process | 3 | 1 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016311 | dephosphorylation | 5 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0036211 | protein modification process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 3 |
GO:0016787 | hydrolase activity | 2 | 3 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 3 |
GO:0016791 | phosphatase activity | 5 | 3 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 3 |
GO:0004721 | phosphoprotein phosphatase activity | 3 | 2 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 2 |
GO:0004725 | protein tyrosine phosphatase activity | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 183 | 185 | PF00675 | 0.402 |
CLV_NRD_NRD_1 | 227 | 229 | PF00675 | 0.415 |
CLV_NRD_NRD_1 | 320 | 322 | PF00675 | 0.350 |
CLV_PCSK_KEX2_1 | 227 | 229 | PF00082 | 0.415 |
CLV_PCSK_KEX2_1 | 320 | 322 | PF00082 | 0.347 |
CLV_PCSK_SKI1_1 | 221 | 225 | PF00082 | 0.348 |
CLV_PCSK_SKI1_1 | 259 | 263 | PF00082 | 0.457 |
CLV_PCSK_SKI1_1 | 4 | 8 | PF00082 | 0.616 |
CLV_PCSK_SKI1_1 | 98 | 102 | PF00082 | 0.288 |
DEG_APCC_DBOX_1 | 258 | 266 | PF00400 | 0.442 |
DOC_CDC14_PxL_1 | 176 | 184 | PF14671 | 0.245 |
DOC_CDC14_PxL_1 | 262 | 270 | PF14671 | 0.315 |
DOC_CKS1_1 | 200 | 205 | PF01111 | 0.359 |
DOC_CYCLIN_RxL_1 | 1 | 11 | PF00134 | 0.398 |
DOC_CYCLIN_yCln2_LP_2 | 39 | 45 | PF00134 | 0.511 |
DOC_MAPK_gen_1 | 184 | 192 | PF00069 | 0.384 |
DOC_MAPK_gen_1 | 254 | 264 | PF00069 | 0.441 |
DOC_MAPK_gen_1 | 47 | 56 | PF00069 | 0.279 |
DOC_MAPK_MEF2A_6 | 20 | 27 | PF00069 | 0.443 |
DOC_MAPK_MEF2A_6 | 309 | 317 | PF00069 | 0.500 |
DOC_MAPK_MEF2A_6 | 47 | 56 | PF00069 | 0.248 |
DOC_MAPK_NFAT4_5 | 49 | 57 | PF00069 | 0.292 |
DOC_PP1_RVXF_1 | 327 | 333 | PF00149 | 0.604 |
DOC_PP2B_LxvP_1 | 37 | 40 | PF13499 | 0.417 |
DOC_USP7_MATH_1 | 146 | 150 | PF00917 | 0.424 |
DOC_USP7_MATH_1 | 18 | 22 | PF00917 | 0.500 |
DOC_USP7_MATH_1 | 353 | 357 | PF00917 | 0.597 |
DOC_USP7_UBL2_3 | 147 | 151 | PF12436 | 0.308 |
DOC_WW_Pin1_4 | 199 | 204 | PF00397 | 0.309 |
DOC_WW_Pin1_4 | 320 | 325 | PF00397 | 0.469 |
LIG_14-3-3_CanoR_1 | 137 | 145 | PF00244 | 0.376 |
LIG_14-3-3_CanoR_1 | 166 | 171 | PF00244 | 0.270 |
LIG_14-3-3_CanoR_1 | 184 | 190 | PF00244 | 0.439 |
LIG_14-3-3_CanoR_1 | 320 | 324 | PF00244 | 0.488 |
LIG_14-3-3_CanoR_1 | 8 | 18 | PF00244 | 0.433 |
LIG_Actin_RPEL_3 | 68 | 87 | PF02755 | 0.175 |
LIG_APCC_ABBA_1 | 66 | 71 | PF00400 | 0.236 |
LIG_EVH1_1 | 37 | 41 | PF00568 | 0.446 |
LIG_FHA_1 | 165 | 171 | PF00498 | 0.342 |
LIG_FHA_1 | 279 | 285 | PF00498 | 0.414 |
LIG_FHA_1 | 299 | 305 | PF00498 | 0.194 |
LIG_FHA_1 | 49 | 55 | PF00498 | 0.250 |
LIG_FHA_2 | 314 | 320 | PF00498 | 0.553 |
LIG_GBD_Chelix_1 | 52 | 60 | PF00786 | 0.245 |
LIG_LIR_Apic_2 | 32 | 38 | PF02991 | 0.445 |
LIG_LIR_Gen_1 | 138 | 146 | PF02991 | 0.431 |
LIG_LIR_Gen_1 | 88 | 97 | PF02991 | 0.309 |
LIG_LIR_Nem_3 | 138 | 143 | PF02991 | 0.288 |
LIG_LIR_Nem_3 | 159 | 164 | PF02991 | 0.370 |
LIG_LIR_Nem_3 | 285 | 290 | PF02991 | 0.488 |
LIG_LIR_Nem_3 | 88 | 92 | PF02991 | 0.268 |
LIG_PDZ_Class_1 | 353 | 358 | PF00595 | 0.579 |
LIG_Pex14_2 | 108 | 112 | PF04695 | 0.402 |
LIG_Pex14_2 | 31 | 35 | PF04695 | 0.483 |
LIG_PTB_Apo_2 | 331 | 338 | PF02174 | 0.436 |
LIG_SH2_CRK | 89 | 93 | PF00017 | 0.405 |
LIG_SH2_NCK_1 | 140 | 144 | PF00017 | 0.199 |
LIG_SH2_STAT5 | 120 | 123 | PF00017 | 0.280 |
LIG_SH2_STAT5 | 178 | 181 | PF00017 | 0.305 |
LIG_SH2_STAT5 | 292 | 295 | PF00017 | 0.299 |
LIG_SH3_1 | 197 | 203 | PF00018 | 0.250 |
LIG_SH3_3 | 197 | 203 | PF00018 | 0.250 |
LIG_SH3_3 | 30 | 36 | PF00018 | 0.352 |
LIG_SH3_3 | 312 | 318 | PF00018 | 0.404 |
LIG_SH3_3 | 38 | 44 | PF00018 | 0.355 |
LIG_SUMO_SIM_par_1 | 187 | 194 | PF11976 | 0.241 |
LIG_SUMO_SIM_par_1 | 50 | 55 | PF11976 | 0.232 |
LIG_SxIP_EBH_1 | 320 | 331 | PF03271 | 0.548 |
LIG_TRFH_1 | 199 | 203 | PF08558 | 0.245 |
LIG_TYR_ITIM | 87 | 92 | PF00017 | 0.308 |
LIG_WW_2 | 41 | 44 | PF00397 | 0.541 |
MOD_CDK_SPK_2 | 199 | 204 | PF00069 | 0.338 |
MOD_CK1_1 | 138 | 144 | PF00069 | 0.384 |
MOD_CK1_1 | 154 | 160 | PF00069 | 0.415 |
MOD_CK2_1 | 138 | 144 | PF00069 | 0.403 |
MOD_CK2_1 | 313 | 319 | PF00069 | 0.544 |
MOD_Cter_Amidation | 182 | 185 | PF01082 | 0.415 |
MOD_GlcNHglycan | 11 | 14 | PF01048 | 0.561 |
MOD_GlcNHglycan | 305 | 308 | PF01048 | 0.474 |
MOD_GlcNHglycan | 334 | 337 | PF01048 | 0.433 |
MOD_GlcNHglycan | 339 | 342 | PF01048 | 0.454 |
MOD_GlcNHglycan | 351 | 354 | PF01048 | 0.607 |
MOD_GSK3_1 | 152 | 159 | PF00069 | 0.305 |
MOD_GSK3_1 | 162 | 169 | PF00069 | 0.201 |
MOD_GSK3_1 | 195 | 202 | PF00069 | 0.323 |
MOD_GSK3_1 | 328 | 335 | PF00069 | 0.466 |
MOD_GSK3_1 | 343 | 350 | PF00069 | 0.428 |
MOD_GSK3_1 | 56 | 63 | PF00069 | 0.292 |
MOD_GSK3_1 | 69 | 76 | PF00069 | 0.292 |
MOD_NEK2_1 | 152 | 157 | PF00069 | 0.334 |
MOD_NEK2_1 | 164 | 169 | PF00069 | 0.190 |
MOD_NEK2_1 | 298 | 303 | PF00069 | 0.376 |
MOD_NEK2_1 | 313 | 318 | PF00069 | 0.385 |
MOD_NEK2_1 | 332 | 337 | PF00069 | 0.276 |
MOD_NEK2_1 | 347 | 352 | PF00069 | 0.477 |
MOD_NEK2_1 | 60 | 65 | PF00069 | 0.283 |
MOD_NEK2_2 | 343 | 348 | PF00069 | 0.427 |
MOD_PIKK_1 | 164 | 170 | PF00454 | 0.271 |
MOD_PK_1 | 185 | 191 | PF00069 | 0.308 |
MOD_PKA_1 | 184 | 190 | PF00069 | 0.415 |
MOD_PKA_2 | 319 | 325 | PF00069 | 0.433 |
MOD_Plk_1 | 343 | 349 | PF00069 | 0.552 |
MOD_Plk_1 | 56 | 62 | PF00069 | 0.232 |
MOD_Plk_4 | 185 | 191 | PF00069 | 0.296 |
MOD_Plk_4 | 328 | 334 | PF00069 | 0.551 |
MOD_Plk_4 | 48 | 54 | PF00069 | 0.237 |
MOD_Plk_4 | 56 | 62 | PF00069 | 0.225 |
MOD_Plk_4 | 82 | 88 | PF00069 | 0.439 |
MOD_ProDKin_1 | 199 | 205 | PF00069 | 0.309 |
MOD_ProDKin_1 | 320 | 326 | PF00069 | 0.472 |
TRG_ENDOCYTIC_2 | 140 | 143 | PF00928 | 0.308 |
TRG_ENDOCYTIC_2 | 178 | 181 | PF00928 | 0.280 |
TRG_ENDOCYTIC_2 | 89 | 92 | PF00928 | 0.377 |
TRG_ER_diArg_1 | 226 | 228 | PF00400 | 0.415 |
TRG_NES_CRM1_1 | 134 | 148 | PF08389 | 0.308 |
TRG_Pf-PMV_PEXEL_1 | 259 | 263 | PF00026 | 0.437 |
TRG_Pf-PMV_PEXEL_1 | 4 | 9 | PF00026 | 0.479 |
TRG_PTS1 | 355 | 358 | PF00515 | 0.568 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P6D2 | Leptomonas seymouri | 75% | 100% |
A0A0S4IR87 | Bodo saltans | 28% | 80% |
A0A0S4IXS3 | Bodo saltans | 33% | 92% |
A0A0S4J698 | Bodo saltans | 33% | 76% |
A0A0S4J952 | Bodo saltans | 35% | 100% |
A0A0S4JFL1 | Bodo saltans | 35% | 100% |
A0A0S4JIG1 | Bodo saltans | 28% | 98% |
A0A0S4JJI6 | Bodo saltans | 44% | 95% |
A0A0S4JU68 | Bodo saltans | 36% | 100% |
A0A1X0NUJ8 | Trypanosomatidae | 53% | 98% |
A0A3S7X7S3 | Leishmania donovani | 100% | 100% |
A0A422N4T2 | Trypanosoma rangeli | 54% | 100% |
A4HAP2 | Leishmania braziliensis | 87% | 100% |
C9ZXU7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 50% | 100% |
C9ZXU8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 51% | 100% |
E9B4U9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
Q4Q377 | Leishmania major | 96% | 100% |
V5B4L5 | Trypanosoma cruzi | 54% | 100% |